International Biotechnology Trust Plc Buys Immunomedics Inc, Exelixis Inc, Regeneron Pharmaceuticals Inc, Sells Merck Inc, Amgen Inc, Eli Lilly and Co

• New Purchases: REGN, BHVN, IMUX,
• Added Positions: IMMU, EXEL, GILD, MYOK, HZNP, ALNY, BMRN, ALXN, PTCT, BIIB,
• Reduced Positions: VRTX, AMGN, INCY, ACAD, ZGNX, IONS, SRPT, KALV, SGEN, NBIX,
• Sold Out: MRK, LLY, AMRN, MLND, ALKS, TCDA,

For the details of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's stock buys and sells, go to https://www.gurufocus.com/guru/international+biotechnology+trust+plc/current-portfolio/portfolio

1. Horizon Therapeutics PLC (HZNP) - 434,000 shares, 7.98% of the total portfolio. Shares added by 10.15%
2. Biomarin Pharmaceutical Inc (BMRN) - 185,584 shares, 7.54% of the total portfolio. Shares added by 9.31%
3. Gilead Sciences Inc (GILD) - 303,284 shares, 7.52% of the total portfolio. Shares added by 27.81%
4. Vertex Pharmaceuticals Inc (VRTX) - 64,822 shares, 6.14% of the total portfolio. Shares reduced by 16.7%
5. Immunomedics Inc (IMMU) - 448,000 shares, 5.10% of the total portfolio. Shares added by 522.22%

International Biotechnology Trust Plc initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $488.29 and $643.92, with an estimated average price of $565.62. The stock is now traded at around $641.23. The impact to a portfolio due to this purchase was 2.33%. The holding were 11,500 shares as of .

International Biotechnology Trust Plc initiated holding in Biohaven Pharmaceutical Holding Co Ltd. The purchase prices were between $29.01 and $74.23, with an estimated average price of $52.75. The stock is now traded at around $72.90. The impact to a portfolio due to this purchase was 1.04%. The holding were 45,000 shares as of .

International Biotechnology Trust Plc initiated holding in Immunic Inc. The purchase prices were between $5.67 and $15.86, with an estimated average price of $10.06. The stock is now traded at around $12.11. The impact to a portfolio due to this purchase was 0.51%. The holding were 123,000 shares as of .

International Biotechnology Trust Plc added to a holding in Immunomedics Inc by 522.22%. The purchase prices were between $9.4 and $36.53, with an estimated average price of $28.93. The stock is now traded at around $40.65. The impact to a portfolio due to this purchase was 4.28%. The holding were 448,000 shares as of .

International Biotechnology Trust Plc added to a holding in Exelixis Inc by 337.09%. The purchase prices were between $16.46 and $27.42, with an estimated average price of $23.03. The stock is now traded at around $23.80. The impact to a portfolio due to this purchase was 2.64%. The holding were 452,534 shares as of .

International Biotechnology Trust Plc added to a holding in Gilead Sciences Inc by 27.81%. The purchase prices were between $72.34 and $84, with an estimated average price of $76.51. The stock is now traded at around $77.19. The impact to a portfolio due to this purchase was 1.64%. The holding were 303,284 shares as of .

International Biotechnology Trust Plc added to a holding in MyoKardia Inc by 315.28%. The purchase prices were between $44.2 and $121.69, with an estimated average price of $82.77. The stock is now traded at around $93.05. The impact to a portfolio due to this purchase was 1.61%. The holding were 65,859 shares as of .

International Biotechnology Trust Plc added to a holding in Alnylam Pharmaceuticals Inc by 62.78%. The purchase prices were between $104.21 and $156.44, with an estimated average price of $134.22. The stock is now traded at around $157.23. The impact to a portfolio due to this purchase was 0.69%. The holding were 36,300 shares as of .

International Biotechnology Trust Plc sold out a holding in Merck & Co Inc. The sale prices were between $73.8 and $83.98, with an estimated average price of $78.88.

International Biotechnology Trust Plc sold out a holding in Eli Lilly and Co. The sale prices were between $136.42 and $164.18, with an estimated average price of $153.12.

International Biotechnology Trust Plc sold out a holding in Amarin Corp PLC. The sale prices were between $4 and $8.26, with an estimated average price of $6.83.

International Biotechnology Trust Plc sold out a holding in Millendo Therapeutics Inc. The sale prices were between $1.4 and $5.28, with an estimated average price of $2.08.

International Biotechnology Trust Plc sold out a holding in Alkermes PLC. The sale prices were between $13.31 and $19.41, with an estimated average price of $16.2.

International Biotechnology Trust Plc sold out a holding in Tricida Inc. The sale prices were between $21.21 and $31.55, with an estimated average price of $27.15.